PubMed:21760535
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 127-256 | DRI_Challenge | denotes | Better understanding of the pathogenesis of spinal cord injury (SCI) is needed for the development of new therapeutic strategies. |
| T2 | 257-428 | DRI_Background | denotes | Spinal cord injury has been investigated in various rodent models, but extrapolation to humans requires the use of a large animal model that more closely mimics human SCI. |
| T3 | 429-541 | DRI_Background | denotes | Dogs frequently develop spontaneous SCI with features that bear a striking resemblance to the human counterpart. |
| T4 | 542-735 | DRI_Approach | denotes | We investigated the temporal course of the immune response during naturally occurring canine SCI and in organotypic canine spinal cord slice cultures that are devoid of peripheral immune cells. |
| T5 | 736-929 | DRI_Background | denotes | By immunohistochemistry, the inflammatory response in subacute canine SCI was largely restricted to resident immune cells as demonstrated by activation of major histocompatibility complex class |
| T6 | 965-966 | DRI_Background | denotes | . |
| T7 | 967-1091 | DRI_Background | denotes | By quantitative polymerase chain reaction, there was parallel upregulation of proinflammatory cytokine gene expression (i.e. |
| T8 | 1092-1204 | DRI_Outcome | denotes | of interleukin 6 [IL-6] and IL-8 with a trend toward upregulation of tumor necrosis factor) in acute canine SCI. |
| T9 | 1337-1626 | DRI_Outcome | denotes | In organotypic spinal cord slices, there was similar activation of major histocompatibility complex class II-positive microglia and prolonged upregulation of inflammatory cytokines, indicating that resident rather than infiltrating cells play major roles in the postinjury immune response. |
| T10 | 1627-1768 | DRI_Approach | denotes | Thus, canine SCI represents a bridge between rodent models and human SCI that may be relevant for clinical and preclinical treatment studies. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 21-31 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
| T2 | 276-279 | CVCL_6758|Undefined_cell_line_type|Cricetulus griseus | denotes | has |
| T3 | 276-279 | CVCL_E689|Transformed_cell_line|Homo sapiens | denotes | has |
| T4 | 372-373 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T5 | 411-417 | CVCL_Z366|Spontaneously_immortalized_cell_line|Spodoptera frugiperda | denotes | mimics |
| T6 | 488-492 | CVCL_0D14|Cancer_cell_line|Canis lupus familiaris | denotes | bear |
| T7 | 493-494 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T8 | 542-544 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | We |
| T9 | 877-887 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
| T10 | 1130-1131 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T11 | 1390-1400 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
| T12 | 1655-1656 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T13 | 1705-1708 | CVCL_E773|Transformed_cell_line|Homo sapiens | denotes | may |
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 61-76 | GO:0006955 | denotes | immune response |
| T2 | 100-106 | UBERON:0003674 | denotes | canine |
| T3 | 107-118 | UBERON:0002240 | denotes | spinal cord |
| T6 | 107-125 | D013119 | denotes | spinal cord injury |
| T7 | 107-125 | D013119 | denotes | spinal cord injury |
| T9 | 155-167 | GO:0009405 | denotes | pathogenesis |
| T10 | 171-182 | UBERON:0002240 | denotes | spinal cord |
| T13 | 171-189 | D013119 | denotes | spinal cord injury |
| T14 | 171-189 | D013119 | denotes | spinal cord injury |
| T16 | 257-268 | UBERON:0002240 | denotes | Spinal cord |
| T19 | 257-275 | D013119 | denotes | Spinal cord injury |
| T20 | 257-275 | D013119 | denotes | Spinal cord injury |
| T22 | 309-315 | D012377 | denotes | rodent |
| T23 | 380-386 | UBERON:3010325 | denotes | animal |
| T24 | 380-386 | UBERON:0000468 | denotes | animal |
| T25 | 418-423 | D006801 | denotes | human |
| T26 | 429-433 | D004285 | denotes | Dogs |
| T27 | 488-492 | 9641 | denotes | bear |
| T28 | 523-528 | D006801 | denotes | human |
| T29 | 585-600 | GO:0006955 | denotes | immune response |
| T30 | 628-634 | UBERON:0003674 | denotes | canine |
| T31 | 658-664 | UBERON:0003674 | denotes | canine |
| T32 | 665-676 | UBERON:0002240 | denotes | spinal cord |
| T33 | 665-676 | D013118 | denotes | spinal cord |
| T34 | 665-676 | D013118 | denotes | spinal cord |
| T36 | 765-786 | GO:0006954 | denotes | inflammatory response |
| T37 | 799-805 | UBERON:0003674 | denotes | canine |
| T38 | 891-923 | GO:0046776 | denotes | major histocompatibility complex |
| T39 | 924-932 | SO:0000182 | denotes | class II |
| T40 | 944-953 | CL:0000129 | denotes | microglia |
| T41 | 994-999 | SO:0000419 | denotes | chain |
| T42 | 994-1008 | MOP:0000635 | denotes | chain reaction |
| T43 | 1070-1074 | SO:0000704 | denotes | gene |
| T44 | 1070-1085 | GO:0010467 | denotes | gene expression |
| T47 | 1095-1108 | P05231 | denotes | interleukin 6 |
| T48 | 1095-1108 | B6CKP4 | denotes | interleukin 6 |
| T49 | 1095-1108 | Q95181 | denotes | interleukin 6 |
| T50 | 1095-1108 | Q28319 | denotes | interleukin 6 |
| T52 | 1095-1108 | P41323 | denotes | interleukin 6 |
| T53 | 1095-1108 | Q6V919 | denotes | interleukin 6 |
| T54 | 1095-1108 | A3FBE9 | denotes | interleukin 6 |
| T55 | 1095-1108 | P46650 | denotes | interleukin 6 |
| T56 | 1095-1108 | Q28747 | denotes | interleukin 6 |
| T57 | 1095-1108 | Q25BC2 | denotes | interleukin 6 |
| T58 | 1095-1108 | Q5I6E3 | denotes | interleukin 6 |
| T59 | 1095-1108 | Q6L6X6 | denotes | interleukin 6 |
| T60 | 1095-1108 | P08505 | denotes | interleukin 6 |
| T61 | 1095-1108 | Q9XT80 | denotes | interleukin 6 |
| T62 | 1095-1108 | A0S0B0 | denotes | interleukin 6 |
| T63 | 1095-1108 | Q865W7 | denotes | interleukin 6 |
| T64 | 1095-1108 | Q9MZR1 | denotes | interleukin 6 |
| T65 | 1095-1108 | Q865X6 | denotes | interleukin 6 |
| T66 | 1095-1108 | P20607 | denotes | interleukin 6 |
| T67 | 1095-1108 | P41693 | denotes | interleukin 6 |
| T68 | 1095-1108 | PR:000001393 | denotes | interleukin 6 |
| T69 | 1095-1108 | Q0GGL7 | denotes | interleukin 6 |
| T70 | 1095-1108 | P51494 | denotes | interleukin 6 |
| T71 | 1095-1108 | P26893 | denotes | interleukin 6 |
| T72 | 1095-1108 | Q2MH06 | denotes | interleukin 6 |
| T73 | 1095-1108 | O35736 | denotes | interleukin 6 |
| T74 | 1095-1108 | P79341 | denotes | interleukin 6 |
| T76 | 1095-1108 | P29455 | denotes | interleukin 6 |
| T77 | 1095-1108 | Q28819 | denotes | interleukin 6 |
| T78 | 1095-1108 | P41683 | denotes | interleukin 6 |
| T79 | 1095-1108 | Q90YI0 | denotes | interleukin 6 |
| T80 | 1095-1108 | Q8MKH0 | denotes | interleukin 6 |
| T81 | 1095-1108 | P26892 | denotes | interleukin 6 |
| T51 | 1095-1108 | D015850 | denotes | interleukin 6 |
| T75 | 1095-1108 | D015850 | denotes | interleukin 6 |
| T82 | 1110-1114 | P05231 | denotes | IL-6 |
| T83 | 1110-1114 | B6CKP4 | denotes | IL-6 |
| T84 | 1110-1114 | Q95181 | denotes | IL-6 |
| T85 | 1110-1114 | Q28319 | denotes | IL-6 |
| T87 | 1110-1114 | P41323 | denotes | IL-6 |
| T88 | 1110-1114 | Q6V919 | denotes | IL-6 |
| T89 | 1110-1114 | A3FBE9 | denotes | IL-6 |
| T90 | 1110-1114 | PR:Q90YI0 | denotes | IL-6 |
| T91 | 1110-1114 | P46650 | denotes | IL-6 |
| T92 | 1110-1114 | Q28747 | denotes | IL-6 |
| T93 | 1110-1114 | Q25BC2 | denotes | IL-6 |
| T94 | 1110-1114 | Q5I6E3 | denotes | IL-6 |
| T95 | 1110-1114 | Q6L6X6 | denotes | IL-6 |
| T96 | 1110-1114 | P08505 | denotes | IL-6 |
| T97 | 1110-1114 | Q9XT80 | denotes | IL-6 |
| T98 | 1110-1114 | A0S0B0 | denotes | IL-6 |
| T99 | 1110-1114 | Q865W7 | denotes | IL-6 |
| T100 | 1110-1114 | Q9MZR1 | denotes | IL-6 |
| T101 | 1110-1114 | PR:P20607 | denotes | IL-6 |
| T102 | 1110-1114 | Q865X6 | denotes | IL-6 |
| T103 | 1110-1114 | PR:P08505 | denotes | IL-6 |
| T104 | 1110-1114 | P20607 | denotes | IL-6 |
| T105 | 1110-1114 | P41693 | denotes | IL-6 |
| T106 | 1110-1114 | PR:000001393 | denotes | IL-6 |
| T107 | 1110-1114 | Q0GGL7 | denotes | IL-6 |
| T108 | 1110-1114 | P51494 | denotes | IL-6 |
| T109 | 1110-1114 | PR:P05231 | denotes | IL-6 |
| T110 | 1110-1114 | P26893 | denotes | IL-6 |
| T111 | 1110-1114 | Q2MH06 | denotes | IL-6 |
| T112 | 1110-1114 | O35736 | denotes | IL-6 |
| T113 | 1110-1114 | P79341 | denotes | IL-6 |
| T115 | 1110-1114 | P29455 | denotes | IL-6 |
| T116 | 1110-1114 | Q28819 | denotes | IL-6 |
| T117 | 1110-1114 | Q90YI0 | denotes | IL-6 |
| T118 | 1110-1114 | P41683 | denotes | IL-6 |
| T120 | 1110-1114 | Q8MKH0 | denotes | IL-6 |
| T121 | 1110-1114 | P26892 | denotes | IL-6 |
| T86 | 1110-1114 | D015850 | denotes | IL-6 |
| T119 | 1110-1114 | D015850 | denotes | IL-6 |
| T114 | 1110-1114 | GO:0005138 | denotes | IL-6 |
| T122 | 1120-1124 | P19874 | denotes | IL-8 |
| T123 | 1120-1124 | PR:000001395 | denotes | IL-8 |
| T124 | 1120-1124 | P10145 | denotes | IL-8 |
| T125 | 1120-1124 | Q102R3 | denotes | IL-8 |
| T126 | 1120-1124 | P67813 | denotes | IL-8 |
| T127 | 1120-1124 | P67814 | denotes | IL-8 |
| T128 | 1120-1124 | P08317 | denotes | IL-8 |
| T129 | 1120-1124 | P79255 | denotes | IL-8 |
| T130 | 1120-1124 | P49113 | denotes | IL-8 |
| T131 | 1120-1124 | P41324 | denotes | IL-8 |
| T132 | 1120-1124 | P26894 | denotes | IL-8 |
| T134 | 1120-1124 | PR:P10145 | denotes | IL-8 |
| T135 | 1120-1124 | P46653 | denotes | IL-8 |
| T136 | 1120-1124 | Q7YRB5 | denotes | IL-8 |
| T137 | 1120-1124 | P36925 | denotes | IL-8 |
| T139 | 1120-1124 | PR:P08317 | denotes | IL-8 |
| T142 | 1120-1124 | Q9XSX5 | denotes | IL-8 |
| T143 | 1120-1124 | O62812 | denotes | IL-8 |
| T133 | 1120-1124 | D016209 | denotes | IL-8 |
| T138 | 1120-1124 | D016209 | denotes | IL-8 |
| T141 | 1120-1124 | CHEBI:138181 | denotes | IL-8 |
| T140 | 1120-1124 | GO:0005153 | denotes | IL-8 |
| T144 | 1161-1166 | D009369 | denotes | tumor |
| T145 | 1161-1166 | D009369 | denotes | tumor |
| T146 | 1161-1182 | P19101 | denotes | tumor necrosis factor |
| T147 | 1161-1182 | Q06599 | denotes | tumor necrosis factor |
| T148 | 1161-1182 | O35734 | denotes | tumor necrosis factor |
| T149 | 1161-1182 | Q8JFG3 | denotes | tumor necrosis factor |
| T152 | 1161-1182 | PR:000000134 | denotes | tumor necrosis factor |
| T153 | 1161-1182 | Q8MKG8 | denotes | tumor necrosis factor |
| T154 | 1161-1182 | P29553 | denotes | tumor necrosis factor |
| T155 | 1161-1182 | P23563 | denotes | tumor necrosis factor |
| T156 | 1161-1182 | P33620 | denotes | tumor necrosis factor |
| T157 | 1161-1182 | P06804 | denotes | tumor necrosis factor |
| T158 | 1161-1182 | Q1WM27 | denotes | tumor necrosis factor |
| T159 | 1161-1182 | Q539C2 | denotes | tumor necrosis factor |
| T160 | 1161-1182 | P59695 | denotes | tumor necrosis factor |
| T161 | 1161-1182 | Q8WNR1 | denotes | tumor necrosis factor |
| T162 | 1161-1182 | Q8HZD9 | denotes | tumor necrosis factor |
| T163 | 1161-1182 | Q75N23 | denotes | tumor necrosis factor |
| T164 | 1161-1182 | O77764 | denotes | tumor necrosis factor |
| T165 | 1161-1182 | P48094 | denotes | tumor necrosis factor |
| T166 | 1161-1182 | P59694 | denotes | tumor necrosis factor |
| T167 | 1161-1182 | P79374 | denotes | tumor necrosis factor |
| T168 | 1161-1182 | Q9BEA1 | denotes | tumor necrosis factor |
| T169 | 1161-1182 | Q2MH05 | denotes | tumor necrosis factor |
| T170 | 1161-1182 | P23383 | denotes | tumor necrosis factor |
| T171 | 1161-1182 | O77510 | denotes | tumor necrosis factor |
| T172 | 1161-1182 | P59693 | denotes | tumor necrosis factor |
| T173 | 1161-1182 | P51742 | denotes | tumor necrosis factor |
| T174 | 1161-1182 | P59684 | denotes | tumor necrosis factor |
| T175 | 1161-1182 | P04924 | denotes | tumor necrosis factor |
| T176 | 1161-1182 | P51435 | denotes | tumor necrosis factor |
| T178 | 1161-1182 | Q1G1A2 | denotes | tumor necrosis factor |
| T179 | 1161-1182 | P01375 | denotes | tumor necrosis factor |
| T180 | 1161-1182 | P13296 | denotes | tumor necrosis factor |
| T181 | 1161-1182 | Q19LH4 | denotes | tumor necrosis factor |
| T182 | 1161-1182 | P16599 | denotes | tumor necrosis factor |
| T183 | 1161-1182 | P79337 | denotes | tumor necrosis factor |
| T184 | 1161-1182 | P36939 | denotes | tumor necrosis factor |
| T185 | 1161-1182 | P51743 | denotes | tumor necrosis factor |
| T150 | 1161-1182 | D014409 | denotes | tumor necrosis factor |
| T151 | 1161-1182 | D014409 | denotes | tumor necrosis factor |
| T177 | 1161-1182 | GO:0005164 | denotes | tumor necrosis factor |
| T186 | 1167-1175 | GO:0019835 | denotes | necrosis |
| T187 | 1167-1175 | GO:0008219 | denotes | necrosis |
| T190 | 1167-1175 | GO:0008220 | denotes | necrosis |
| T191 | 1167-1175 | GO:0001906 | denotes | necrosis |
| T192 | 1167-1175 | GO:0070265 | denotes | necrosis |
| T188 | 1167-1175 | D009336 | denotes | necrosis |
| T189 | 1167-1175 | D009336 | denotes | necrosis |
| T193 | 1193-1199 | UBERON:0003674 | denotes | canine |
| T194 | 1235-1244 | D016207 | denotes | cytokines |
| T195 | 1235-1244 | D016207 | denotes | cytokines |
| T196 | 1251-1256 | PR:000001471 | denotes | IL-10 |
| T197 | 1251-1256 | Q29408 | denotes | IL-10 |
| T198 | 1251-1256 | P18893 | denotes | IL-10 |
| T199 | 1251-1256 | PR:Q6A2H4 | denotes | IL-10 |
| T200 | 1251-1256 | Q25BC1 | denotes | IL-10 |
| T201 | 1251-1256 | Q9TSJ4 | denotes | IL-10 |
| T202 | 1251-1256 | O97798 | denotes | IL-10 |
| T203 | 1251-1256 | P46651 | denotes | IL-10 |
| T204 | 1251-1256 | P51497 | denotes | IL-10 |
| T205 | 1251-1256 | O46673 | denotes | IL-10 |
| T206 | 1251-1256 | P29456 | denotes | IL-10 |
| T207 | 1251-1256 | Q8MKG9 | denotes | IL-10 |
| T208 | 1251-1256 | Q6A2H4 | denotes | IL-10 |
| T209 | 1251-1256 | P79338 | denotes | IL-10 |
| T211 | 1251-1256 | Q29055 | denotes | IL-10 |
| T212 | 1251-1256 | P48411 | denotes | IL-10 |
| T213 | 1251-1256 | PR:P29456 | denotes | IL-10 |
| T214 | 1251-1256 | Q2PE73 | denotes | IL-10 |
| T215 | 1251-1256 | A2T6Z6 | denotes | IL-10 |
| T216 | 1251-1256 | PR:P22301 | denotes | IL-10 |
| T217 | 1251-1256 | Q865X4 | denotes | IL-10 |
| T218 | 1251-1256 | Q5Q0V6 | denotes | IL-10 |
| T219 | 1251-1256 | Q9Z1Y5 | denotes | IL-10 |
| T220 | 1251-1256 | PR:P18893 | denotes | IL-10 |
| T221 | 1251-1256 | P55029 | denotes | IL-10 |
| T222 | 1251-1256 | P43480 | denotes | IL-10 |
| T223 | 1251-1256 | P47965 | denotes | IL-10 |
| T224 | 1251-1256 | P22301 | denotes | IL-10 |
| T226 | 1251-1256 | Q9JHK7 | denotes | IL-10 |
| T227 | 1251-1256 | Q0Z972 | denotes | IL-10 |
| T229 | 1251-1256 | P51746 | denotes | IL-10 |
| T230 | 1251-1256 | Q28374 | denotes | IL-10 |
| T231 | 1251-1256 | P51496 | denotes | IL-10 |
| T210 | 1251-1256 | D016753 | denotes | IL-10 |
| T225 | 1251-1256 | D016753 | denotes | IL-10 |
| T228 | 1251-1256 | GO:0005141 | denotes | IL-10 |
| T232 | 1282-1308 | D015291 | denotes | transforming growth factor |
| T233 | 1282-1308 | D015291 | denotes | transforming growth factor |
| T234 | 1295-1308 | P08441 | denotes | growth factor |
| T235 | 1295-1308 | P08072 | denotes | growth factor |
| T236 | 1295-1308 | Q776B5 | denotes | growth factor |
| T237 | 1295-1308 | Q6RZT5 | denotes | growth factor |
| T238 | 1295-1308 | Q8V307 | denotes | growth factor |
| T239 | 1352-1363 | UBERON:0002240 | denotes | spinal cord |
| T240 | 1352-1363 | D013118 | denotes | spinal cord |
| T241 | 1352-1363 | D013118 | denotes | spinal cord |
| T243 | 1404-1436 | GO:0046776 | denotes | major histocompatibility complex |
| T244 | 1437-1445 | SO:0000182 | denotes | class II |
| T245 | 1455-1464 | CL:0000129 | denotes | microglia |
| T246 | 1508-1517 | D016207 | denotes | cytokines |
| T247 | 1508-1517 | D016207 | denotes | cytokines |
| T248 | 1610-1625 | GO:0006955 | denotes | immune response |
| T249 | 1633-1639 | UBERON:0003674 | denotes | canine |
| T250 | 1672-1678 | D012377 | denotes | rodent |
| T251 | 1690-1695 | D006801 | denotes | human |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-126 | Sentence | denotes | Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury. |
| T2 | 127-256 | Sentence | denotes | Better understanding of the pathogenesis of spinal cord injury (SCI) is needed for the development of new therapeutic strategies. |
| T3 | 257-428 | Sentence | denotes | Spinal cord injury has been investigated in various rodent models, but extrapolation to humans requires the use of a large animal model that more closely mimics human SCI. |
| T4 | 429-541 | Sentence | denotes | Dogs frequently develop spontaneous SCI with features that bear a striking resemblance to the human counterpart. |
| T5 | 542-735 | Sentence | denotes | We investigated the temporal course of the immune response during naturally occurring canine SCI and in organotypic canine spinal cord slice cultures that are devoid of peripheral immune cells. |
| T6 | 736-966 | Sentence | denotes | By immunohistochemistry, the inflammatory response in subacute canine SCI was largely restricted to resident immune cells as demonstrated by activation of major histocompatibility complex class II-expressing microglia/macrophages. |
| T7 | 967-1204 | Sentence | denotes | By quantitative polymerase chain reaction, there was parallel upregulation of proinflammatory cytokine gene expression (i.e. of interleukin 6 [IL-6] and IL-8 with a trend toward upregulation of tumor necrosis factor) in acute canine SCI. |
| T8 | 1205-1336 | Sentence | denotes | Expression of neuroprotective cytokines (e.g. IL-10) remained unchanged, and transforming growth factor β upregulation was delayed. |
| T9 | 1337-1626 | Sentence | denotes | In organotypic spinal cord slices, there was similar activation of major histocompatibility complex class II-positive microglia and prolonged upregulation of inflammatory cytokines, indicating that resident rather than infiltrating cells play major roles in the postinjury immune response. |
| T10 | 1627-1768 | Sentence | denotes | Thus, canine SCI represents a bridge between rodent models and human SCI that may be relevant for clinical and preclinical treatment studies. |
| T1 | 0-126 | Sentence | denotes | Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury. |
| T2 | 127-256 | Sentence | denotes | Better understanding of the pathogenesis of spinal cord injury (SCI) is needed for the development of new therapeutic strategies. |
| T3 | 257-428 | Sentence | denotes | Spinal cord injury has been investigated in various rodent models, but extrapolation to humans requires the use of a large animal model that more closely mimics human SCI. |
| T4 | 429-541 | Sentence | denotes | Dogs frequently develop spontaneous SCI with features that bear a striking resemblance to the human counterpart. |
| T5 | 542-735 | Sentence | denotes | We investigated the temporal course of the immune response during naturally occurring canine SCI and in organotypic canine spinal cord slice cultures that are devoid of peripheral immune cells. |
| T6 | 736-966 | Sentence | denotes | By immunohistochemistry, the inflammatory response in subacute canine SCI was largely restricted to resident immune cells as demonstrated by activation of major histocompatibility complex class II-expressing microglia/macrophages. |
| T7 | 967-1204 | Sentence | denotes | By quantitative polymerase chain reaction, there was parallel upregulation of proinflammatory cytokine gene expression (i.e. of interleukin 6 [IL-6] and IL-8 with a trend toward upregulation of tumor necrosis factor) in acute canine SCI. |
| T8 | 1205-1336 | Sentence | denotes | Expression of neuroprotective cytokines (e.g. IL-10) remained unchanged, and transforming growth factor β upregulation was delayed. |
| T9 | 1337-1626 | Sentence | denotes | In organotypic spinal cord slices, there was similar activation of major histocompatibility complex class II-positive microglia and prolonged upregulation of inflammatory cytokines, indicating that resident rather than infiltrating cells play major roles in the postinjury immune response. |
| T10 | 1627-1768 | Sentence | denotes | Thus, canine SCI represents a bridge between rodent models and human SCI that may be relevant for clinical and preclinical treatment studies. |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21760535_1_0 | 171-189 | expanded | denotes | spinal cord injury |
| SS2_21760535_1_0 | 191-194 | abbr | denotes | SCI |
| SS1_21760535_6_0 | 1095-1108 | expanded | denotes | interleukin 6 |
| SS2_21760535_6_0 | 1110-1114 | abbr | denotes | IL-6 |
| AE1_21760535_1_0 | SS1_21760535_1_0 | SS2_21760535_1_0 | abbreviatedTo | spinal cord injury,SCI |
| AE1_21760535_6_0 | SS1_21760535_6_0 | SS2_21760535_6_0 | abbreviatedTo | interleukin 6,IL-6 |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1161-1166 | HP_0002664 | denotes | tumor |